Neurotechnology Articles & Analysis
18 news found
Before that, he served as a group president at Stryker overseeing the MedSurg and Neurotechnology businesses at Stryker from 2008 to 2018. Having played a pivotal role in the success of Stryker and having held several vital leadership roles within the organization, Mr. ...
He will continue to play a key role in driving the company’s research and development strategy as the company delivers its next generation of transformative neurotechnology innovations to the neuroscience research community. EMOTIV is a recognized pioneer and market leader in the field of neurotechnology and is backed and trusted by the scientific, ...
Neurolief Ltd., a neurotechnology innovator, today announced enrollment of the first patient in its pivotal clinical study evaluating Relivion® DP for the treatment of major depressive disorder (MDD). ...
Neurolief, a neurotechnology innovator, today announced new data released at the 64th Annual Scientific Meeting hosted by the American Headache Society (June 9-12th, 2022, Denver, CO). ...
Neurolief, a neurotechnology innovator, today announces the publication of the SP301 study in the Pain and Therapy Journal that demonstrates the safety and efficacy of Relivion MG, Neurolief’s CE-marked and FDA cleared wearable neuromodulation system for at-home treatment of migraine with remote physician monitoring. ...
These tests are widely used in the field of neurotechnology allowing for comparison between NeuroOne's electrodes and other approaches in academic and industry settings. ...
” About BrainScope BrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care. ...
About BrainScope BrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care. ...
This is a $5.8B TAM, and Noleus is a seed-stage company with issued IP with a 510K FDA pathway. Novela Neurotechnologies, Inc. is commercializing nEureka®, a patient-first data platform that enables personalized remote care for epilepsy. nEureka® leverages smart wearables to empower users to manage all aspects of their epilepsy, 24/7. ...
This is a $5.8B TAM, and Noleus is a seed-stage company with issued IP with a 510K FDA pathway. Novela Neurotechnologies, Inc. is commercializing nEureka®, a patient-first data platform that enables personalized remote care for epilepsy. nEureka® leverages smart wearables to empower users to manage all aspects of their epilepsy, 24/7. ...
” “Progress in improving rehabilitation outcomes for stroke patients has historically been challenging, but the market authorization of the IpsiHand System promises to usher in a bright future for our stroke patients and allows us to support their recovery throughout the rehabilitation process,” said Eric Leuthardt, MD, Chief Scientific Officer of Neurolutions and Chief of ...
Neurolief, an innovator in neurotechnology, announces the company has received Food and Drug Administration (FDA) clearance for its Relivion® system. ...
Neurolief Ltd., a neurotechnology innovator, today announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co., Ltd. for the development and marketing of Relivion®, a non-invasive digital medical device for migraine and depression, in Japan. ...
Neurolief, a neurotechnology innovator, today announces findings of the RIME US pivotal trial that demonstrate the safety and efficacy of the Relivion®, a novel external brain neuromodulation system for self-administered treatment of migraine. ...
BrainScope, a medical neurotechnology company that is a pioneer in the use of A.I. and machine learning in the creation of biomarkers of brain injuries and disease was selected from five finalists as the company with the most commercial potential at the 5th Annual BioHealth Capital Region Crab Trap Competition. ...
Neurolief, a medical neurotechnology innovator, today announces that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Relivion®DP system, the first non-invasive multi-channel brain neuromodulation technology, for the treatment of major depression. ...
Included in the 2020 shortlist are: Dr Gregoire Courtine is Full Professor of Neuroscience and Neurotechnology in the Center for Neuroprosthetics at the Swiss Federal Institute of Technology Lausanne. ...
Coalition members include: Algae Biomass Organization (ABO), Association of Clinical Research Organizations (ACRO), Advanced Medical Technology Association (AdvaMed), Biotechnology Industry Organization (BIO), Center for Innovative Technology (CIT), Commercial Spaceflight Federation (CSF),CONNECT, Electricity Storage Association (ESA), Fuel Cell & Hydrogen Energy Association (FCHEA), Medical ...